Atrium Therapeutics
RNA11.9753.77% ( +0.435 )
Forecast & Rating3 analysts currently cover Atrium Therapeutics, of which 3 give a positive rating. The average price target is $25.00, about 109.8% upside from the current price of $11.92. Coverage is limited, so the data is for reference only. Data as of Jul 14, 2026; this does not constitute investment advice.
Jul 14, 2026Price forecast
$25.00109.82%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineAug 2, 2026
Forecast met46.9%
Stock price$11.92
Average forecast price$74.6
Highest forecast price$96
Lowest forecast price$72
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.